Lung Cancer in France.
暂无分享，去创建一个
P. Giraud | J. Pujol | M. Denis | B. Trétarre | P. Thomas | S. Bommart | B. Roch
[1] P. Laurent-Puig,et al. Predictive molecular pathology in non–small cell lung cancer in France: The past, the present and the perspectives , 2020, Cancer cytopathology.
[2] G. Defossez,et al. Multidimensional penalized splines for incidence and mortality-trend analyses and validation of national cancer-incidence estimates. , 2020, International journal of epidemiology.
[3] Ahmad AlMulla,et al. Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019. , 2019, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[4] P. Pagès,et al. Comparison of Epithor clinical national database and medico-administrative database to identify the influence of case-mix on the estimation of hospital outliers , 2019, PloS one.
[5] A. Bezjak,et al. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial , 2017, The Lancet. Oncology.